AVITA Medical's 15-min chart indicates MACD Death Cross and Bearish Marubozu.

Based on the 15-minute chart of AVITA Medical, a significant technical indicator known as the MACD Death Cross has been triggered, accompanied by a Bearish Marubozu pattern on August 22nd, 2023 at 12:15. This suggests that the stock price has the potential to continue declining, with sellers dominating the market, and bearish momentum likely to persist.

Synopsys, a leading provider of software solutions for chip design, is currently facing significant technical pressure and a 3.09% price drop due to U.S. export curbs on China [1]. The Trump administration's new restrictions on semiconductor design software sales to China have directly impacted Synopsys, leading to a suspension of sales and services in the region. This regulatory pressure is likely to affect the company's revenue in the region.

Quest Software, another significant player in the software market, has recently raised $350 million to accelerate AI innovation. This capital infusion could indirectly influence the software and semiconductor design market by boosting AI development [1]. Additionally, Rivian and Volkswagen's collaboration aims to develop software-defined vehicle platforms, which could create new demand for chip design tools and indirectly benefit Synopsys in the long term [1].

Analysts are divided on Synopsys, with an average rating of 4.50 and a performance-weighted rating of 1.62. Despite strong fundamentals with an internal diagnostic score of 6.54, the current price fall aligns with a pessimistic outlook. Key analysts, such as Blair Abernethy of Rosenblatt and Lee Simpson of Morgan Stanley, have shown poor historical accuracy in their ratings [1].

Technical conditions for Synopsys are weak, with three bearish indicators active and no bullish ones. The technical score is 2.75, reflecting poor momentum and a high risk of further decline. The MACD Death Cross, a significant bearish signal, was triggered on August 6th, 2025, indicating a potential reversal in the stock price [1]. Additionally, a Bearish Marubozu pattern was observed on August 22nd, 2023, at 12:15, suggesting sellers dominating the market and bearish momentum likely to persist [1].

Investors are advised to wait for stability amid regulatory pressures and weak momentum. The current environment suggests watching for follow-through in both price and fundamentals to avoid downside risk. The company's strong fundamentals, such as a Return on Equity of 3.48% and a Net Profit Margin of 21.51%, remain reasonably robust [1].

References:
[1] https://www.ainvest.com/news/stock-analysis-synopsys-outlook-technical-weakness-mixed-analyst-views-signal-cautious-approach-2508/